The 10-year breast cancer risk in women with BRCA1/BRCA2-associated ovarian cancer was 11%, compared to 28% in the control group (mortality rates at five and ten years were 33% and 61%, respectively). This evidence concerns the gene BRCA2 and breast carcinoma.